Resultados de la búsqueda 2031-2040 of 14726 for the understanding and treatment of gynecological conditions

  1. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Understanding triple-negative breast cancer and its treatment Jan. 04, 2024, 04:00 p.m. CDT; Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters ...

  2. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Understanding triple-negative breast cancer and its treatment Jan. 04, 2024, 04:00 p.m. CDT; Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters ...

  3. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Breast Cancer Discussions. nlb122 · Something new in the treatment arsenal? 62 Replies Fri, Jun 27, 2025.

  4. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Understanding triple-negative breast cancer and its treatment Jan. 04, 2024, 04:00 p.m. CDT; Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters ...

  5. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Understanding triple-negative breast cancer and its treatment Jan. 04, 2024, 04:00 p.m. CDT; Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters ...

  6. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Understanding triple-negative breast cancer and its treatment Jan. 04, 2024, 04:00 p.m. CDT; Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters ...

  7. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Understanding triple-negative breast cancer and its treatment Jan. 04, 2024, 04:00 p.m. CDT; Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters ...

  8. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Understanding triple-negative breast cancer and its treatment Jan. 04, 2024, 04:00 p.m. CDT; Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters ...

  9. Cáncer de mama - Médicos y departamentos - Mayo Clinic

    Understanding triple-negative breast cancer and its treatment Jan. 04, 2024, 04:00 p.m. CDT; Mayo Clinic's DNA study reveals BRCA1 mutations in 3 sisters ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen receptor positive/ ...